Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9775858 | 0.86 | HSD17B10 (0.58) | ESR1ESR2KDM4EALDH1A1PLA2G10 | |
| SCHEMBL21310428 | 0.86 | HSD17B10 (0.58) | ESR1ESR2KDM4EALDH1A1PLA2G10 | |
| SCHEMBL28825756 | 0.83 | ESR1 (0.52) | ESR1ESR2KDM4EALDH1A1PLA2G10 | |
| SCHEMBL28338869 | 0.83 | ESR1 (0.52) | ESR1ESR2KDM4EALDH1A1PLA2G10 | |
| SCHEMBL28595339 | 0.83 | ESR1 (0.52) | ESR1ESR2KDM4EALDH1A1PLA2G10 | |
| SCHEMBL7624177 | 0.83 | ESR1 (0.52) | ESR1ESR2KDM4EALDH1A1PLA2G10 | |
| SCHEMBL26567857 | 0.78 | TDP1 (0.48) | ESR1ESR2HSD17B10MDM2MAPK1 | |
| SCHEMBL3864662 | 0.78 | ESR1 (1.00) | ESR1ESR2KDM4EALDH1A1HPGD | |
| SCHEMBL22403888 | 0.78 | ESR1 (0.63) | ESR1ESR2KDM4EALDH1A1PLA2G10 | |
| SCHEMBL6422263 | 0.78 | KDM4E (0.54) | ESR1ESR2KDM4EALDH1A1PLA2G10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458522-B1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM SPA (IT) | 2024-01-03 | — | — | EP | claimed |
| CN-115449108-B | proton exchange membrane | 中国科学院福建物质结构研究所 | 2023-11-17 | — | — | CN | claimed |
| CN-115449108-A | Proton exchange membrane | 中国科学院福建物质结构研究所 | 2022-12-09 | — | — | CN | claimed |
| CN-113277970-B | Tetraphenylpyrrole derivative containing carbonyl and preparation method and application thereof | 南京工业大学 | 2022-10-18 | — | — | CN | claimed |
| CN-113277970-A | Tetraphenylpyrrole derivative containing carbonyl and preparation method and application thereof | 南京工业大学 | 2021-08-20 | — | — | CN | claimed |
| US-10723710-B2 | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | ICROM S.P.A. (IT) | 2020-07-28 | — | — | US | claimed |
| US-20190185440-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM S.P.A. (IT) | 2019-06-20 | — | — | US | claimed |
| EP-3458522-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | Icrom SpA (IT) | 2019-03-27 | — | — | EP | claimed |
| US-9856364-B2 | Stabilized reversible polymer composition | XEROX CORPORATION (US) | 2018-01-02 | — | — | US | claimed |
| WO-2017199162-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM S.P.A. (IT) | 2017-11-23 | — | — | WO | claimed |
| US-20140353549-A1 | STABILIZED REVERSIBLE POLYMER COMPOSITION | XEROX CORPORATION (US) | 2014-12-04 | — | — | US | claimed |
| CN-102186643-A | Enhanced surfaces, coatings and related methods | INNOVA METERIALS LLC | 2011-09-14 | — | — | CN | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | claimed |
| CN-1089086-C | Luminandide medicine | MILLS RANDELL L (US) | 2002-08-14 | — | — | CN | claimed |
| EP-0414730-B1 | Chemical Compounds and pharmaceutical compositions capable of releasing a drug | MILLS RANDELL L (US) | 1999-12-15 | — | — | EP | claimed |
| US-5773592-A | COMPRISES A CHEMILUMINESCENT MOIETY, A PHOTOCHROMIC MOIETY AND A BIOLOGICALLY ACTIVE AGENT CAPABLE OF BEING RELEASED | MILLS RANDELL LEE (US) | 1998-06-30 | — | — | US | claimed |
| EP-0717054-A2 | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1996-06-19 | — | — | EP | claimed |
| US-5449724-A | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1995-09-12 | — | — | US | claimed |
| JP-58176639-A | — | — | None | — | — | JP | disclosed |
| US-4082551-A | GOOD ADHESION AND BLOCKING POSITIVE CHARGED PARTICLES | EASTMAN KODAK COMPANY (US) | 1978-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | ESR1 362/4885ESR2 507/4885KDM4E 3072/4885 |
| US-10723710-B2 | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | DDT, QDPR, DDC | ESR1 4575/4885ESR2 4454/4885KDM4E 1531/4885 |
| US-20190185440-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | DDT, QDPR, DDC | ESR1 4575/4885ESR2 4454/4885KDM4E 1531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.